Photo by finnnyc from unsplash
INTRODUCTION AND OBJECTIVE:Although several large-scale studies reported a robust benefit of upfront therapy for mHNPC, not all patients with mHNPC experienced mCRPC progression. As there is a conc... Click to show full abstract
INTRODUCTION AND OBJECTIVE:Although several large-scale studies reported a robust benefit of upfront therapy for mHNPC, not all patients with mHNPC experienced mCRPC progression. As there is a conc...
Keywords:
therapy;
burden eligibility;
upfront therapy;
mp37 association;
tumor burden;
association tumor
Journal Title: Journal of Urology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Urology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!